Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Botox will not be around 4 yrs from now. Unfortunate truth.
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="anonymous, post: 5976146"]Revance:::</p><p><br /></p><p>Study Design: Phase 2, Randomized, Double-Blind, Dose Ranging, Active and Placebo Controlled, Multi-Center Study conducted at 9 Canadian sites</p><p><br /></p><p><br /></p><p>•All Three Doses of RT002 had Higher Rate of Response vs. Onabot (BOTOX) 20U on ≥ 1 Point Improvement in IGA-FWS</p><p><br /></p><p>•Compared to Onabot (BOTOX) 20U, • RT002 40U had higher rate of response at all time points through 24 Weeks • RT002 20U had higher rate of response at all time points through 20 Weeks</p><p><br /></p><p>•Longer Duration of Response Observed for all Three Doses of RT002 (BOTOX) vs. Onabot 20U: ≥ 1 Point Improvement in IGA-FWS</p><p><br /></p><p><br /></p><p>Summary of Safety </p><p><br /></p><p>•All five groups exhibited an excellent overall safety profile • No serious adverse events • Adverse events were predominantly localized, transient and mild in severity and typically injection related (erythema and pain)</p><p><br /></p><p>Summary of Duration</p><p><br /></p><p>•Duration: 6-month median duration of > 1 point improvement on IGA-FWS with RT002 40U, with 23.6 weeks vs.18.8 weeks (BOTOX) for onabot 20U (p=0.030)[/QUOTE]</p><p><br /></p>
[QUOTE="anonymous, post: 5976146"]Revance::: Study Design: Phase 2, Randomized, Double-Blind, Dose Ranging, Active and Placebo Controlled, Multi-Center Study conducted at 9 Canadian sites •All Three Doses of RT002 had Higher Rate of Response vs. Onabot (BOTOX) 20U on ≥ 1 Point Improvement in IGA-FWS •Compared to Onabot (BOTOX) 20U, • RT002 40U had higher rate of response at all time points through 24 Weeks • RT002 20U had higher rate of response at all time points through 20 Weeks •Longer Duration of Response Observed for all Three Doses of RT002 (BOTOX) vs. Onabot 20U: ≥ 1 Point Improvement in IGA-FWS Summary of Safety •All five groups exhibited an excellent overall safety profile • No serious adverse events • Adverse events were predominantly localized, transient and mild in severity and typically injection related (erythema and pain) Summary of Duration •Duration: 6-month median duration of > 1 point improvement on IGA-FWS with RT002 40U, with 23.6 weeks vs.18.8 weeks (BOTOX) for onabot 20U (p=0.030)[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Botox will not be around 4 yrs from now. Unfortunate truth.
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Allergan
>
Botox will not be around 4 yrs from now. Unfortunate truth.
>